Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | TTR | P02766 | 1/20 | 0.52 |
| ▸ | PPOX | P50336 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.48 |
| ▸ | HTR2A | P28223 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.45 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL204622 | 1.00 | FFAR1 (0.58) | FFAR1MEN1KMT2ATTRPPOX | |
| Hydrochloric Acid SCHEMBL10642889 | 0.99 | FFAR1 (0.57) | FFAR1MEN1KMT2ATTRPPOX | |
| SCHEMBL10642883 | 0.91 | FFAR1 (0.53) | FFAR1MEN1KMT2ATTRPPOX | |
| SCHEMBL9420232 | 0.91 | FFAR1 (0.67) | FFAR1MEN1KMT2ATTRPPOX | |
| SCHEMBL10644341 | 0.90 | FFAR1 (0.52) | FFAR1MEN1KMT2ATTRPPOX | |
| Hydrochloric Acid SCHEMBL10942896 | 0.90 | FFAR1 (0.65) | FFAR1MEN1KMT2ATTRPPOX | |
| SCHEMBL941173 | 0.89 | FFAR1 (0.51) | FFAR1MEN1KMT2ATTRPPOX | |
| SCHEMBL29382403 | 0.89 | FFAR1 (0.51) | FFAR1MEN1KMT2ATTRPPOX | |
| SCHEMBL147772 | 0.89 | FFAR1 (0.51) | FFAR1MEN1KMT2ATTRPPOX | |
| SCHEMBL10615272 | 0.88 | FFAR1 (0.58) | FFAR1MEN1KMT2ATTRPPOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140208463-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING SPECIFIC TETRAMIC ACID DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-07-24 | — | — | US | claimed |
| WO-2013020985-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING SPECIFIC TETRAMIC ACID DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-02-14 | — | — | WO | claimed |
| EP-0179015-B1 | 7-(ARYLOXY)-2-NAPHTHOXYALKANECARBOXYLIC ACID DERIVATIVES, PROCESSES FOR THE PREPARATION OF THESE COMPOUNDS, AS WELL AS AGENTS HAVING HERBICIDAL ACTIVITY CONTAINING THESE COMPOUNDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-04-13 | — | — | EP | claimed |
| US-4709077-A | 7-(aryloxy)-2-naphthoxyalkanecarboxylic acid derivatives, processes for the preparation of these compounds, as well as agents having herbicidal activity containing these compounds | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-11-24 | — | — | US | claimed |
| EP-0179015-A1 | 7-(Aryloxy)-2-naphthoxyalkanecarboxylic acid derivatives, processes for the preparation of these compounds, as well as agents having herbicidal activity containing these compounds | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-04-23 | — | — | EP | claimed |
| US-11700852-B2 | Aqueous electrolyte-containing adjuvant compositions, active ingredient-containing compositions and the use thereof | CLARIANT INTERNATIONAL LTD (CH) | 2023-07-18 | — | — | US | disclosed |
| US-20220411370-A1 | Solvates Of Abscisic Acid And Liquid Compositions Containing Abscisic Acid | CLARIANT INTERNATIONAL LTD. (CH) | 2022-12-29 | — | — | US | disclosed |
| US-20220183282-A1 | Fatty Acid Derivatives For Improving The Effect Of Agrochemical Actives | CLARIANT INTERNATIONAL LTD. (CH) | 2022-06-16 | — | — | US | disclosed |
| US-11304418-B2 | Substituted n-(-1,3,4-oxadiazole-2-yl)aryl carboxamides and the use thereof as herbicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT | 2022-04-19 | — | — | US | disclosed |
| EP-3930467-A1 | FATTY ACID DERIVATIVES FOR IMPROVING THE EFFECT OF AGROCHEMICAL ACTIVES | Clariant International Ltd (CH) | 2022-01-05 | — | — | EP | disclosed |
| WO-2021099079-A9 | SOLVATES OF ABSCISIC ACID AND LIQUID COMPOSITIONS CONTAINING ABSCISIC ACID | CLARIANT INTERNATIONAL LTD (CH) | 2021-08-12 | — | — | WO | disclosed |
| CN-107205379-B | Aqueous adjuvant composition containing electrolyte, composition containing active ingredient and use thereof | 科莱恩国际有限公司 | 2021-08-10 | — | — | CN | disclosed |
| US-20130310254-A1 | Alpha, beta-unsaturated imines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-11-21 | — | — | US | disclosed |
| EP-2561759-A1 | Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth | Bayer Cropscience AG (DE) | 2013-02-27 | — | — | EP | disclosed |
| WO-2013020985-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING SPECIFIC TETRAMIC ACID DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-02-14 | — | — | WO | disclosed |
| US-20130023413-A1 | HERBICIDAL COMPOSITIONS FOR TOLERANT OR RESISTANT SOYBEAN CROPS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-24 | — | — | US | disclosed |
| US-20120157306-A1 | Substituted Fused Pyrimidinones and Dihydropyrimidinones | BAYER CROPSCIENCE AG (DE) | 2012-06-21 | — | — | US | disclosed |
| US-20120157314-A1 | NOVEL SUBSTITUTED PICOLINIC ACIDS, SALTS AND ACID DERIVATIVES THEREOF, AND USE THEREOF AS HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2012-06-21 | — | — | US | disclosed |
| US-20110294663-A1 | Herbicidal composition for tolerant or resistant corn crops | BAYER CROPSCIENCE AG (DE) | 2011-12-01 | — | — | US | disclosed |
| US-5695773-A | APPLYING ONTO PLANT A DILUENT AND A SOLUTION CONSISTING OF OXYNIL AND A HERBICIDE IN LIQUID STATE | CFPI AGRO (FR) | 1997-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294663-A1 | Herbicidal composition for tolerant or resistant corn crops | CRY1, CYP8B1, CNPY2 | FFAR1 1990/4885MEN1 2859/4885KMT2A 853/4885 |
| US-20120157314-A1 | NOVEL SUBSTITUTED PICOLINIC ACIDS, SALTS AND ACID DERIVATIVES THEREOF, AND USE THEREOF AS HERBICIDES | HPD, ALAD, DDT | FFAR1 438/4885MEN1 4524/4885KMT2A 3445/4885 |
| US-20130310254-A1 | Alpha, beta-unsaturated imines | TTPA, ECH1, GSTO1 | FFAR1 1079/4885MEN1 2014/4885KMT2A 4517/4885 |
| US-20220183282-A1 | Fatty Acid Derivatives For Improving The Effect Of Agrochemical Actives | ELOVL1, FFAR1, ELOVL3 | FFAR1 2/4885MEN1 402/4885KMT2A 757/4885 |
| US-11700852-B2 | Aqueous electrolyte-containing adjuvant compositions, active ingredient-containing compositions and the use thereof | AQP1, PHOSPHO1, AQP3 | FFAR1 3064/4885MEN1 1795/4885KMT2A 2250/4885 |
| US-20120157306-A1 | Substituted Fused Pyrimidinones and Dihydropyrimidinones | DHPS, FDPS, DPYD | FFAR1 1377/4885MEN1 3414/4885KMT2A 3719/4885 |
| US-20140208463-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING SPECIFIC TETRAMIC ACID DERIVATIVES | DDT, TBCA, CA3 | FFAR1 2431/4885MEN1 3621/4885KMT2A 3045/4885 |
| US-11304418-B2 | Substituted n-(-1,3,4-oxadiazole-2-yl)aryl carboxamides and the use thereof as herbicides | DDT, NAT1, AADAC | FFAR1 1476/4885MEN1 4181/4885KMT2A 771/4885 |
| US-20220411370-A1 | Solvates Of Abscisic Acid And Liquid Compositions Containing Abscisic Acid | BROX, AQP3, AQP1 | FFAR1 1300/4885MEN1 4634/4885KMT2A 2827/4885 |
| US-20130023413-A1 | HERBICIDAL COMPOSITIONS FOR TOLERANT OR RESISTANT SOYBEAN CROPS | CTH, GGH, CBR3 | FFAR1 1381/4885MEN1 4054/4885KMT2A 975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.